Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Multiple Myeloma"
topic_facet:"Leukemia"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Multiple+Myeloma%22&filter%5B%5D=topic_facet%3A%22Leukemia%22&lookfor=%22Myeloma%22&type=Subject
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Multiple+Myeloma%22&filter%5B%5D=topic_facet%3A%22Leukemia%22&lookfor=%22Myeloma%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Multiple+Myeloma%22&filter%5B%5D=topic_facet%3A%22Leukemia%22&lookfor=%22Myeloma%22&type=Subject
PubPharm (324)
1
Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation : A Randomized Phase II Study to Compare the Net Clinical Benefit of Cyclosporine and Sirolimus Combined With MMF or Post-Transplant Cyclophosphamide as GVHD Prophylaxis After HLA-Matched or HLA-Mismatched Unrelated G-CSF Mobilized Blood Cell Transplantation Using Nonmyeloablative or Reduced Intensity Conditioning for Patients With Hematologic Malignancies
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
VSV-hIFNbeta-NIS in Treating Patients With Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma : Phase I Trial of Systemic Administration of Vesicular Stomatitis Virus Genetically Engineered to Express NIS and Human Interferon, in Patients With Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia, Lymphomas, or Histiocytic/Dendritic Cell Neoplasms
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
Natural Killer Cells and Bortezomib to Treat Cancer : Safety and the Anti- Tumor Effects of Escalating Doses of Adoptively Infused Ex Vivo Expanded Autologous Natural Killer (NK) Cells Against Metastatic Cancers or Hematological Malignancies Sensitized to NK-TRAIL Cytotoxicity With Bortezomib
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders : Myeloablative Allogeneic Hematopoietic Cell Transplantation Using a Related or Unrelated Donor for the Treatment of Hematological Diseases
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
VOB560-MIK665 Combination First in Human Trial in Patients With Hematological Malignancies (Relapsed/Refractory Non-Hodgkin Lymphoma, Relapsed/Refractory Acute Myeloid Leukemia, or Relapsed/Refractory Multiple Myeloma) : A Phase Ib, Multicenter Study of VOB560 in Combination With MIK665 in Patients With Relapsed/Refractory Non-Hodgkin Lymphoma, Relapsed/Refractory Acute Myeloid Leukemia, or Relapsed/Refractory Multiple Myeloma.
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Nivolumab for Relapsed, Refractory, or Detectable Disease Post Chimeric Antigen Receptor T-cell Treatment in Patients With Hematologic Malignancies : Nivolumab for Relapsed or Refractory Disease Post Chimeric Antigen Receptor T-Cell Treatment in Patients With Hematologic Malignancies
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection : Blinded Reference Set for Multicancer Early Detection Blood Tests
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
Expanded Access to Venetoclax : Expanded Access to Venetoclax
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer : A Phase II Trial of Haploidentical Allogeneic Stem Cell Transplantation Utilizing Mobilized Peripheral Blood Stem Cells
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant : A Phase I Trial to Evaluate Safety and Immunogenicity of a Cytomegalovirus Peptide Vaccine Co-Injected With PF-03512676 Adjuvant in Recipients of Allogeneic Hematopoietic Stem Cell Transplant
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[33]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Multiple Myeloma
Filter aufheben
Thema: Leukemia
Medienart
320
Aufsätze
316
E-Ressourcen
314
E-Artikel
6
Gedruckte Aufsätze
4
Bücher
2
E-Books
2
Gedruckte Bücher
Alle anzeigen ...
weniger ...
Zeitschriftentitel
305
ClinicalTrials.gov
6
Reactions weekly
3
Inpharma weekly
2
Cancer chemotherapy and pharmacology
1
Annals of hematology
1
Frontiers in Pharmacology
1
Journal of Postgraduate Medicine
Alle anzeigen ...
weniger ...
Thema
Leukemia
Multiple Myeloma
305
610
264
Study Type: Interventional
220
Lymphoma
196
Myelodysplastic Syndromes
175
Neoplasms, Plasma Cell
158
Recruitment Status: Completed
127
Precursor Cell Lymphoblastic Leukemia-Lymphoma
127
Preleukemia
126
Leukemia, Lymphocytic, Chronic, B-Cell
118
Leukemia, Myeloid
116
Syndrome
115
Myeloproliferative Disorders
103
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
101
Leukemia, Lymphoid
98
Leukemia, Myeloid, Acute
82
Phase: Phase 2
80
Lymphoma, Non-Hodgkin
80
Phase: Phase 1
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
312
2000-
5
1900-1999
Erscheinungsjahr(e)
Von:
Bis:
Sprache
324
Englisch
Haven't found what you're looking for?
Wird geladen...